PL EN


2014 | 4 | 1 | 18-23
Article title

Body mass analysis in patients with Hashimoto thyroiditis

Content
Title variants
Languages of publication
EN
Abstracts
EN
Introduction: Hashimoto thyroiditis (HT) is one of the most common autoimmune thyroid disorders and o the most common cause of hypothyroidism, but the relation between TSH and body mass is still unclear. Material and methods: The group studied consisted of 53 patients with HT in euthyreosis and 28 healthy individuals. All the patients underwent thyroid ultrasonography and body mass analysis with the use of a medical analyzer INBODY 200. Blood samples were also analyzed for TSH and anti-thyroid antibodies. Results: The patients with HT had higher body mass (p=0.008), body mass index (BMI) (p=0.02), Waist-Hip Ratio (WHR) (0.01) and fat mass (p=0.02) than had the controls. In HT group increased body mass was observed in 72% of the patients (overweight in 38% and obesity in 35% of them), as compared with 38% of overweight/obesity in the control group. Thyroid volume was significantly lower (p=0.01) and anti-peroxidase antibodies level was two times higher in the group with the treatment period > 2 years, but the patients with relatively short treatment period were 7 kg heavier and their fat mass was 6 kg higher than in the subjects treated longer than 2 years. Conclusions: Our results suggest that the patients with HT, even in euthyreosis, have significantly higher body mass, BMI, WHR and fat mass than healthy individuals, which is probably associated with previous disturbances that led to the increase in fat mass at the stage of hypothyroidism. The observed changes tend to normalize during L-thyroxine replacement therapy.
Year
Volume
4
Issue
1
Pages
18-23
Physical description
Contributors
References
  • Weetman AP. Thyroid disease. In The Autoimmune Disease. Edited by Rose NR, Mackay IR. Elsevier. 2006; p. 467-82.
  • Ando T, Davies TF. Self-recognition and the role of fetal microchimerism. Best Pract Res Clin Endocrinol Metab. 2004 Jun; 18(2):197-211.
  • Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev. 2003 May; 2(3):119-25.
  • Pierce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003 Jun 26; 348:2646-55.
  • Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW. Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J. Clin Endocrinol Metab. 2009 Jun; 94(6):1853–7.
  • Nymes A, Jorde R, Sundsfjord J. Serum TSH is positively associated with BMI. Int J Obes. 2006 Jan; 30(1):100-5.
  • Reinehr T, Isa A, Soussa G, Dieffenbach R, Andler W. Thyroid hormones and their relation to weight status. Horm Res. 2008; 70(1):51-7.
  • Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol. 2010Mar 25; 316(2):165–71.
  • Sestoft L. Metabolic aspects of the calorigenic effect of thyroid hormone in mammals. Clin Endocrinol, 1980Nov; 13(5):489–506.
  • Shalitin S, Yackobovitch-Gacan M, Phillip M. Prevalence of thyroid function in obese children and adolescents before and afterweight reduction and its relation to other metabolic parameters. Horm Res. 2009; 71(3):155-61.
  • Bhowmick SK, Dasari G, Levens KL, Rettig KR. The prevalence of elevated serum thyroid-stimulating hormone in childhood/adolescents obesity and of autoimmune thyroid diseases in a subgroup. J Nat Med Assoc. 2007Jul; 99(7): 773-6.
  • Knudsen N, Laurberg P, Rasmussen LB, Bulow I, Perrild H, Ovesen L, Jorgensen T. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab. 2005Jul; 90(7):4019–24.
  • Nyrnes A, Jorde R, Sundsfjord J. Serum TSH is positively associated with BMI. Int J Obes. 2006 Jan; 30(1):100–5.
  • Fox CS, Pencina MJ, D’Agostino RB, Murabito JM, Seely EW, Pearce EN, Vasan RS. Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch Intern Med. 2008 Mar 24;168(6):587–92.
  • Manji N, Boelaert K, Sheppard MC, Holder RL, Gough SC, Franklyn JA. Lack of association between serum TSH or free T4 and body mass index in euthyroid subjects. Clin Endocrinol. 2006 Feb; 64(2):125–8.
  • Glass AR, Kushner J. Obesity, nutrition, and the thyroid. Endocrinologist. 1996;6:392–404.
  • Plummer WA. Body weight in spontaneous myxedema. Transactions of the American Asso-ciation for the Study of Goiter. 1940:88–98.
  • Karmisholt J, Andersen S, Laurberg P. Weight loss after therapy of hypothyroidism is mainly caused by excretion of excess body water associated with myxoedema. J Clin Endocrinol Metab. 2011 Jan; 96(1): E99–103.
  • Michalaki MA, Vagenakis AG, Leonardou AS, Argentou MN, Habeos IG, Makri MG, Psyrogiannis AI, Kalfarentzos FE, Kyriazo-poulou VE. Thyroid function in humans with morbid obesity. Thyroid 2006 Jan; 16 (1):73–8.
  • Rotondi M, Magri F, Chiovato L. Thyroid and obesity: not a one-way interaction. J Clin Endocrinol Metab. 2011 Feb; 96(2):344–6.
  • Rotondi M, Leporati P, La Manna A, Pirali B, Mondello T, Fonte R, Magri F, Chiovato L. Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism? Eur J Endocrinol. 2009 Mar; 160(3):403–8.
  • Marzullo P, Minocci A, Tagliaferri MA, Guzzaloni G, Di Blasio A, De Medici C, Aimaretti G, Liuzzi A. Investigations of thyroid hormones and antibodies in obesity: leptin levels are associated with thyroid autoimmunity independent of bioanthropometric, hormonal and weight-related determinants. J Clin Endocrinol Metab. 2010 Aug; 95(8):3965–72.
  • Diez JJ, Iglesias P. Relationship between thyreotropin and body mass index in euthyroid subjects. Exp Clin Endocrinol Diabetes. 2011 Mar; 119(3):144-50.
  • Iacobellis G, Ribuado MC, Zappaterreno A, Iannucci CV, Di Mario U, Leonetti F. Relation-ship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endorcinol. 2008 Apr; 62(4):487-91.
  • Zimmermann-Belsing T, Brabant G, Holst JJ, Feldt-Rasmussen U. Circulating leptin and thyroid dysfunction. Eur J Endocrinol. 2003 Oct; 149(4):257–71.
  • Menendez C, Baldelli R, Camina JP, Escudero B, Peino R, Dieguez C, Casanueva FF. TSH stimulates leptin secretion by a direct effect on adipocytes. J Endocrinol. 2003 Jan; 176(1):7–12.
  • Rosenbaum M, Goldsmith R, Bloomfield D, Magnano, Weimer L, Heymsfield S, Gallagher D, Mayer L, Murphy E, Leibel RL. Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest. 2005 Dec; 115(12):3579–86.
  • Hegedüs L, Hansen JM, Feldt-Rasmussen U, Hansen BM, Høier-Madsen M. Influence of thyroxine treatment on thyroid size and anti-thyroid peroxidase antibodies in Hashimoto's thyroiditis. Clin Endocrinol (Oxf). 1991;35 (3): 235-8.
  • Romaldini JH1, Biancalana MM, Figueiredo DI, Farah CS, Mathias PC. Effect of L-thyroxine administration on antithyroid antibody levels, lipid profile, and thyroid volume in patients with Hashimoto's thyroiditis. Thyroid. 1996; 6(3):183-8.
  • Boothby WM, Sandiford I. Normal values of basal or standard metabolism. A modification of the Dubois standards. Am J Physiol. 1929, 90:290–1.
  • Garber JR, Cobin RH, Gharib H, J.V. Hennessey JV, Klein I, Mechanick JI, R. Pessah-Pollack R, Singer PA. Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endo-crinologists and the American Thyroid Association. Thyroid. 2012; 22(12):1200-35.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.desklight-dbbcb417-1e7f-4d5d-bc28-2d6b3e8f06d5
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.